Abortifacient development should not be stifled.
Dahm
D
D
University of Virginia School of Medicine.
D000019:Abortifacient Agents; D000021:Abortifacient Agents, Steroidal; D002681:China; D004363:Drug Utilization; D004963:Estrenes; D005260:Female; D005602:France; D006801:Humans; D015735:Mifepristone; D011247:Pregnancy; D014481:United States
D000019:Abortifacient Agents; D000021:Abortifacient Agents, Steroidal; D004963:Estrenes; D015735:Mifepristone